Navigation Links
Alcon Commences Phase 2 Clinical Trial of NovaBay's NVC-422 for Viral Conjunctivitis
Date:7/5/2009

EMERYVILLE, Calif. and HUENENBERG, Switzerland, July 5 /PRNewswire-FirstCall/ -- Alcon, Inc. (NYSE: ACL) and its partner, NovaBay Pharmaceuticals, Inc. (NYSE-AMEX: NBY), announced today that Alcon has begun treating patients in a Phase 2 clinical trial of NovaBay's patented lead Aganocide(R) compound, NVC-422, for viral conjunctivitis, a type of "pink eye". Conjunctivitis is a pervasive and painful condition that affects both adults and children, leading to more than four million doctor and emergency room visits in the United States each year.

NovaBay has a licensing and research collaboration agreement with Alcon, the world's leading eye care company, for use of its Aganocide(R) compounds in the eye, ear and sinus, and in contact lens solutions.

Developed by NovaBay to mimic the body's defense against infection, Aganocides(R) are proprietary synthetic analogs of the same molecules used by white blood cells to destroy harmful microbes in the body, such as viruses and bacteria. Because of their natural mechanism of action, NovaBay believes that Aganocide(R) compounds have a low potential for generating microbial resistance, offering a potential solution to the problem of rising resistance of microbes to traditional antibiotics.

The Phase 2 viral conjunctivitis study follows a recently completed Phase 1 trial in which safety and tolerability were successfully demonstrated in 120 healthy volunteers with no reported serious adverse events.

"We are pleased to be entering mid-stage clinical testing for viral conjunctivitis," said Ron Najafi, Ph.D., chairman and chief executive officer of NovaBay. "This is the first step in the ophthalmic clinical development program for NVC-422, which has the immediate goal o
'/>"/>

SOURCE NovaBay Pharmaceuticals, Inc.; Alcon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. ORBIS and Alcon Call Attention to the Aging Eye
2. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
3. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
4. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
5. VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology
6. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
7. Oramed Pharmaceuticals Commences Phase 2A Trials of its Oral Insulin Capsule on Type 1 Diabetics
8. Logical Therapeutics Inc. Commences Double-Blind, Randomized Study of Their Lead Program, LT-NS001
9. Cytopia Commences Second Phase II Study in Brain Cancer
10. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
11. Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... February 9 Hoya Corporation today,announced financial ... 2009 .,Net sales were 106.8 billion yen ... yen in the same period last year. Operating ... from 16.6 billion yen in the same ... productivity. Compared to the second,quarter ended September 30, ...
(Date:2/9/2010)... Feb. 9 Sanofi-aventis (EURONEXT: SAN and ... has successfully completed its tender offer for all outstanding ...   ,, The tender offer and withdrawal rights expired ... on February 8, 2010 .  The depositary for ... the expiration time, approximately 18,611,072 shares of Chattem common ...
(Date:2/8/2010)... BRUNSWICK, N.J. , Feb. 8 ... that the company will release financial results for the ... the market on Thursday, February 25, 2010 . ... Gionco, Group Vice President and Chief Financial Officer, will ... 10:00 a.m. Eastern Time on February 26, ...
Breaking Medicine Technology:Hoya Announces Third Quarter Financial Results 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 2Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 3Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 4Sanofi-aventis Successfully Completes Tender Offer for Chattem, Inc. 5Savient Pharmaceuticals To Hold Fourth Quarter And Year-End 2009 Results Conference Call On Friday, February 26, 2010 2Statement of IUE CWA President Jim Clark on GMs Emergence From Bankruptcy 51362 1Illinois Cemetery and Funeral Home Association Condemns Burr Oak Crimes 51360 1Illinois Cemetery and Funeral Home Association Condemns Burr Oak Crimes 51360 2Stillbirth Not an Issue for Next Born 51358 1Stillbirth Not an Issue for Next Born 51358 2
... and "Dr. Siegal,s Cookie Diet" Were the Top Two ... "John McCain" Rounded Out the Top 5, MCLEAN, ... distributor of Dr. Siegal,s COOKIE DIET(R),hunger-controlling foods, today announced ... McCain named Sarah Palin his running mate, "Dr. Siegal,s,Cookie ...
... Cancer patients,have complained for years about the ... at West Virginia University, researchers have discovered,that injections ... the,memory loss that breast cancer chemotherapy drugs sometimes ... in the September issue of the,journal Metabolic Brain ...
Other Medicine Technology:Sarah Palin, Dr. Siegal's Cookie Diet, and John McCain Top AOL Hot Searches List on August 29th 2Study Suggests a Possible Way to Offset Chemobrain Memory Loss 2
(Date:2/9/2010)... -- The National Coalition for Cancer ... the Commission on Cancer (CoC), a multidisciplinary organization ... to reducing the morbidity and mortality of cancer ... quality of care. ,, The CoC has ... join with its members, efforts to improve the ...
(Date:2/9/2010)... the importance of a clean credit report and informs consumers ... ... Delray Beach, FL (PRWEB) February 9, ... and credit monitoring services, today announced the importance of ensuring ... to improve their credit reports should they contain inaccuracies. ...
(Date:2/9/2010)... Heart Association’s Go Red For Women® Movement to Fight Heart ... , ... Central Coast, CA (PRWEB) February ... Obispo and Santa Barbara Counties announce their participation in year ... that launched on February 1, 2010. Benefiting the American ...
(Date:2/9/2010)... payments for bladder biopsies done in doctor,s office ... 9 (HealthDay News) -- After Medicare sweetened payments ... New York City practice performed many more in-office ... stayed roughly the same, a new study finds. ... rose 50 percent after the U.S. Centers for ...
(Date:2/9/2010)... The American Council on Exercise (ACE), ... the largest fitness certification, education and training organizations ... an exclusive study on the benefits of kettlebell ... , La Crosse , through its exercise ... a much higher-intensity workout than standard weight-training routines ...
Breaking Medicine News(10 mins):Health News:The National Coalition for Cancer Survivorship Joins the Commission on Cancer 2Health News:NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010 2Health News:Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 2Health News:Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 3Health News:Central Coast Jiffy Lube Service Centers Embark on Year Three of Successful Maintenance Partners For Life Campaign 4Health News:Medicare Cost-Saving Moves Can Backfire 2Health News:Medicare Cost-Saving Moves Can Backfire 3Health News:American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time 2Health News:American Council on Exercise (ACE) Study Reveals Kettlebells Provide Powerful Workout in Short Amount of Time 3
... Group on Health, a national non-profit organization of ... and,dedication to promoting a healthy workplace and encouraging ... Sanofi-aventis U.S. was among 52 employers that received ... Leadership Summit sponsored,by the National Business Group on ...
... Pharmaceuticals Inc.,has announced that EUFLEXXA(R) (1% sodium hyaluronate), its ... will serve as a sponsor,for the Babolat World Tennis ... Category II United States Tennis,Association sanctioned tournament held in ... largest adult tennis tournament of its kind in the,world, ...
... insurance executive to lead BCBSIL,s sales and,marketing, ... been,named divisional senior vice president, Local and Consumer ... (BCBSIL). In his new role, Freer,will oversee small, ... throughout Illinois, as well as manage HMO Illinois. ...
... triggers of,childhood asthma, OAKLAND, Calif., May 13 ... asthma triggers,that leave millions of children gasping for air. ... California Endowment lays out a plan for what,we all ... healthier., The new report, Breathing Easy from Home ...
... RELEASE, 13 May 200] Scientists at the Swedish medical ... that a receptor called ALK7 plays important roles in ... the release of insulin from beta-cells in the pancreas. ... against diabetes and obesity. , We have shown ...
... 13, 2008 Individuals with autism spectrum disorders ... communications, and display repetitive behaviors and abnormal responses ... autistic childs impaired social abilities is their lack ... and hugging that strengthen social bonds. On ...
Other Medicine News:Health News:Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health 2Health News:Sanofi-aventis Named One of Best Employers for Healthy Lifestyles by National Business Group on Health 3Health News:Ferring Pharmaceuticals' EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic 2Health News:Ferring Pharmaceuticals' EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic 3Health News:Ferring Pharmaceuticals' EUFLEXXA(R) to Serve as a Sponsor for the Babolat World Tennis Classic 4Health News:Blue Cross and Blue Shield of Illinois Names New Vice President, Local and Consumer Markets 2Health News:Why Our Kids Can't Breathe in Our Communities 2Health News:Why Our Kids Can't Breathe in Our Communities 3Health News:Novel mechanisms controlling insulin release and fat deposition discovered 2Health News:Genetic links to impaired social behavior in autism 2
This EIA microplate opens new perspectives in the direct detection of Chlamydia. The choice of microplate immunoenzymatic technology and the use of a monoclonal antibody result in a combination of c...
... Pathfinder RSV EIA Kit is a direct antigen ... aspirates. It uses polyclonal and monoclonal antibodies ... This assay combines the specificity and reproducibility of ... an EIA. Qualitative results are availalbe within ...
... BrachyStar® Needle is designed to help you ... clinically effective brachytherapy procedure. All needles are ... and polished surfaces for smooth entry and ... and sizes assures an ideal match with ...
... Brachytherapy loaders allow for efficient, easy ... Connectors to your customized plans at ... Bard loaders is the flexibility to ... flexibility of the patented SourceLink™ Connector ...
Medicine Products: